Turn on more accessible mode
Turn off more accessible mode
Sign In
Back to hamad.qa
عربي
Staff login
  • Your Health
  • Allergy and Immunology Awareness Program (AIAP)
  • Allergy
  • Immunodeficiency
  • Kid's Corner
  • Publications
  • News
  • Videos
  • Media
  • Contact us

Food Allergies

  • Special Toothpaste for Treating of Adults with Peanut Allergy
  • Omalizumab is likely to be the first medicine to treat multiple food allergies in 2024
  • Latest Information on Sesame Allergy
  • Omalizumab is Approved by the FDA as the First Medicine for Treatment of Multiple Food Allergies
  • Finding Early Skin Biomarkers to Predict Future Food Allergies
  • FDA Approves Peanut Oral Immunotherapy for Children Aged 1 to 3 Years
  • Colostrum Feeding and Food Allergy Prevention
  • A diverse diet early in life may reduce the risk of food allergies
  • Omalizumab is Better Than Oral Immunotherapy in Treating Multi-food Allergies

Food Allergies

  •  
  • Your Health
  •  
  • Allergy and Immunology Awareness Program (AIAP)
  •  
  • News
  •  
  • Allergy
  •  
  • Food Allergies

​​

  • Our Partners

  • Our Accreditations

  • National Insurance Scheme

Hamad Medical Corporation

HMC is the principal public healthcare provider in the State of Qatar, delivering the safest, most effective and most compassionate care to each and every one of our patients.

  • Hamad Medical Corporation
  • PO Box 3050
    (+974) 4439 5777
  • Doha, Qatar
    contactus@hamad.qa
  •  
  •  
  •  
  •  
  •  

Latest Facebook Posts

  • Loading...

Latest Twitter Posts

  • Loading...
Tweets by HMC_Qatar
Privacy Notice. © Copyright - Hamad Medical Corporation by Corporate Communications Dept.
Top